Literature DB >> 8375926

Incidence of infiltrating cancer following superficial bladder carcinoma.

F Levi1, C La Vecchia, L Randimbison, S Franceschi.   

Abstract

Patients with histologically confirmed first diagnosis of superficial bladder carcinoma notified to the population-based cancer registry of the Swiss Canton of Vaud during the calendar period 1974-90 were actively followed-up to December 31, 1990 for the occurrence of a subsequent invasive tumour of the urinary bladder. Among 1,012 incident cases of superficial bladder neoplasms, followed for a total of 6,286 person/years at risk, 93 infiltrating tumours of the urinary bladder were diagnosed. Only 5.3 cases were expected on the basis of the general population of the canton. The overall standardized incidence ratio (SIR) was 17.5 (95% confidence interval, CI: 14.2-21.7). The SIR was significantly greater for females than for males. The SIR was highest between 1 and 4 years following registration of non-infiltrating cancer, and declined thereafter. The cumulative risk of invasive bladder cancer was 7%, 13%, and 16%, after 5, 10 and 15 years, respectively. This work provides population-based, accurate and reliable estimates of the risk of invasive bladder cancer following non-infiltrating cancers. Although the overall relative risk was almost 20-fold higher than in the general population, the cumulative risk of developing an invasive bladder cancer was only 16% at 15 years.

Entities:  

Mesh:

Year:  1993        PMID: 8375926     DOI: 10.1002/ijc.2910550316

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

Review 1.  Recent Advances in Improved Anticancer Efficacies of Camptothecin Nano-Formulations: A Systematic Review.

Authors:  Maryam Ghanbari-Movahed; Tea Kaceli; Arijit Mondal; Mohammad Hosein Farzaei; Anupam Bishayee
Journal:  Biomedicines       Date:  2021-04-27

2.  Incidence of invasive cancers following carcinoma in situ of the cervix.

Authors:  F Levi; L Randimbison; C La Vecchia; S Franceschi
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

3.  Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study.

Authors:  N Lange; P Jichlinski; M Zellweger; M Forrer; A Marti; L Guillou; P Kucera; G Wagnières; H van den Bergh
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

4.  A Systematic Review of the Preventive and Therapeutic Effects of Naringin Against Human Malignancies.

Authors:  Maryam Ghanbari-Movahed; Gloria Jackson; Mohammad Hosein Farzaei; Anupam Bishayee
Journal:  Front Pharmacol       Date:  2021-03-29       Impact factor: 5.810

5.  PHLPP2 stabilization by p27 mediates its inhibition of bladder cancer invasion by promoting autophagic degradation of MMP2 protein.

Authors:  Minggang Peng; Jingjing Wang; Dongyun Zhang; Honglei Jin; Jingxia Li; Xue-Ru Wu; Chuanshu Huang
Journal:  Oncogene       Date:  2018-06-21       Impact factor: 9.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.